543213 Stock Overview Engages in manufacture and sale of specialty chemicals in India and internationally. More details
Rewards Risk Analysis No risks detected for 543213 from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Add noteRossari Biotech Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Rossari Biotech Historical stock prices Current Share Price ₹785.15 52 Week High ₹966.00 52 Week Low ₹657.80 Beta 0.27 1 Month Change -3.28% 3 Month Change -15.76% 1 Year Change -1.83% 3 Year Change -37.99% 5 Year Change n/a Change since IPO 5.77%
Recent News & Updates
Now 22% undervalued after recent price drop Oct 22
Rossari Biotech Limited Appoints Gurudas Aras as an Additional Director Designated as Non- Executive Independent Director Oct 21
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Oct 20
Rossari Biotech Limited to Report Q2, 2025 Results on Oct 19, 2024 Oct 11
Price target increased by 7.6% to ₹951 Sep 30
Rossari Biotech Limited Approves Dividend for the Financial Year Ended 31 March, 2024 Aug 24 See more updates
Now 22% undervalued after recent price drop Oct 22
Rossari Biotech Limited Appoints Gurudas Aras as an Additional Director Designated as Non- Executive Independent Director Oct 21
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Oct 20
Rossari Biotech Limited to Report Q2, 2025 Results on Oct 19, 2024 Oct 11
Price target increased by 7.6% to ₹951 Sep 30
Rossari Biotech Limited Approves Dividend for the Financial Year Ended 31 March, 2024 Aug 24
Upcoming dividend of ₹0.50 per share Aug 09
Rossari Biotech Limited, Annual General Meeting, Aug 23, 2024 Jul 22
First quarter 2025 earnings: EPS and revenues exceed analyst expectations Jul 21
Rossari Biotech Limited to Report Q1, 2025 Results on Jul 20, 2024 Jul 13
Full year 2024 earnings: EPS misses analyst expectations Apr 30
Rossari Biotech Limited to Report Q4, 2024 Results on Apr 29, 2024 Apr 22
Now 20% undervalued Feb 05
Price target increased by 9.0% to ₹852 Jan 25
Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Jan 21
Investor sentiment improves as stock rises 17% Dec 06
Price target decreased by 8.4% to ₹782 Oct 28
Second quarter 2024 earnings released: EPS: ₹5.97 (vs ₹4.34 in 2Q 2023) Oct 22
Rossari Biotech Limited to Report Q2, 2024 Results on Oct 21, 2023 Oct 14
First quarter 2024 earnings released: EPS: ₹5.30 (vs ₹5.21 in 1Q 2023) Jul 30
Rossari Biotech Limited to Report Q1, 2024 Results on Jul 29, 2023 Jul 25
Rossari Biotech Limited Announces Resignation of Melier Castelino as an Independent Director Jul 06
Investor sentiment improves as stock rises 16% Jun 07 Rossari Biotech Limited Appoints Ms. Aparna Sharma , as A Non-Executive, Independent Director, Effective 29Th April, 2023
Upcoming dividend of ₹0.50 per share at 0.1% yield May 17
Rossari Biotech Limited, Annual General Meeting, May 31, 2023 May 07
Rossari Biotech Limited, Annual General Meeting, May 31, 2023 May 06
Full year 2023 earnings: EPS and revenues miss analyst expectations Apr 30
Investor sentiment improves as stock rises 23% Apr 10
Price target decreased by 9.2% to ₹986 Feb 07
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Feb 05
Rossari Biotech Limited Announces Resignation of Robin Banerjee as Non-Executive Independent Director Jan 05
Insufficient new directors Dec 02
Consensus forecasts updated Nov 16
Consensus forecasts updated Nov 12
Second quarter 2023 earnings released: EPS: ₹4.34 (vs ₹4.77 in 2Q 2022) Nov 06
Rossari Biotech Limited to Report Q2, 2023 Results on Nov 05, 2022 Oct 30
First quarter 2023 earnings released: EPS: ₹5.21 (vs ₹4.52 in 1Q 2022) Aug 07
Rossari Biotech Limited to Report Q1, 2023 Results on Aug 06, 2022 Jul 30
Rossari Biotech Limited Approves Dividend for the Financial Year Ended March 31, 2022, Payable on or After July 21, 2022 Jul 16
Upcoming dividend of ₹0.50 per share Jun 30
Full year 2022 earnings: EPS misses analyst expectations Jun 25
Rossari Biotech Limited Recommended Final Dividend for the Financial Year Ended March 31, 2022, Payable on or After July 21, 2022 Jun 24
Full year 2022 earnings: EPS in line with analyst expectations despite revenue beat May 22
Rossari Biotech Limited Proposes Final Dividend for the Financial Year Ended March 31, 2022 May 21 Rossari Biotech Limited, Annual General Meeting, Jul 15, 2022
Price target decreased to ₹1,252 Apr 27
Consensus revenue estimates increase by 26% Feb 21
Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat Feb 16
Price target decreased to ₹1,330 Feb 16
Second quarter 2022 earnings released: EPS ₹4.77 (vs ₹4.07 in 2Q 2021) Nov 03
Insider recently sold ₹2.1m worth of stock Aug 08
Price target increased to ₹1,270 Aug 03
First quarter 2022 earnings released: EPS ₹4.52 (vs ₹3.19 in 1Q 2021) Jul 31
Rossari Biotech Reportedly in Advanced Talks to Acquire Specialty Chemicals Business Jul 16
Rossari Biotech Limited (BSE:543213) entered in an agreement to acquire Unitop Chemicals Pvt. Ltd. for approximately INR 4.2 billion. Jun 03
Full year 2021 earnings released: EPS ₹15.56 (vs ₹13.42 in FY 2020) May 15
Rossari Biotech Limited announced that it expects to receive INR 2.999997816 billion in funding from Malabar Investments, LLC, State Bank of India, Asset Management Arm and other investors Mar 25
New 90-day high: ₹1,036 Feb 20
Third quarter 2021 earnings released: EPS ₹4.16 Jan 24
Rossari Biotech Limited to Report Q3, 2021 Results on Jan 23, 2021 Jan 16
Investor sentiment improved over the past week Dec 29
Investor sentiment improved over the past week Dec 23
New 90-day high: ₹859 Dec 22
New 90-day high: ₹839 Dec 03
First half earnings released Oct 25
Rossari Biotech Limited to Report Q2, 2021 Results on Oct 24, 2020 Oct 20 Shareholder Returns 543213 IN Chemicals IN Market 7D -3.4% -3.1% -3.2% 1Y -1.8% 3.8% 18.7%
See full shareholder returns
Return vs Market: 543213 underperformed the Indian Market which returned 18.7% over the past year.
Price Volatility Is 543213's price volatile compared to industry and market? 543213 volatility 543213 Average Weekly Movement 4.8% Chemicals Industry Average Movement 5.8% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.1% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 543213 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 543213's weekly volatility (5%) has been stable over the past year.
About the Company Rossari Biotech Limited engages in manufacture and sale of specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names.
Show more Rossari Biotech Limited Fundamentals Summary How do Rossari Biotech's earnings and revenue compare to its market cap? 543213 fundamental statistics Market cap ₹43.45b Earnings (TTM ) ₹1.39b Revenue (TTM ) ₹19.24b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 543213 income statement (TTM ) Revenue ₹19.24b Cost of Revenue ₹13.50b Gross Profit ₹5.74b Other Expenses ₹4.36b Earnings ₹1.39b
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 25.07 Gross Margin 29.85% Net Profit Margin 7.21% Debt/Equity Ratio 12.8%
How did 543213 perform over the long term?
See historical performance and comparison Dividends
0.06% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/25 01:09 End of Day Share Price 2024/12/24 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Rossari Biotech Limited is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution null null Anand Rathi Shares and Stock Brokers Limited Bhawana Israni Anand Rathi Shares and Stock Brokers Limited Rohit Nagraj Centrum Broking Limited
Show 2 more analysts